Meritage Portfolio Management Supernus Pharmaceuticals, Inc. Transaction History

Meritage Portfolio Management

$1.55 Billion
Q2 2025

A detailed history of Meritage Portfolio Management transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Meritage Portfolio Management holds 60,398 shares of SUPN stock, worth $2.9 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

60,398

Previous 58,803 2.71%

Holding current value

$2.9 Million

Previous $1.93 Million 1.14%

% of portfolio

0.12%

Previous 0.13%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 25, 2025	BUY	$30.29 - $33.43 $48,312 - $53,320	1,595 Added 2.71%	60,398 $1.9 Million
Q1 2025 Apr 28, 2025	BUY	$31.17 - $40.0 $331,087 - $424,880	10,622 Added 22.05%	58,803 $1.93 Million
Q4 2024 Jan 27, 2025	BUY	$31.89 - $37.83 $123,924 - $147,007	3,886 Added 8.77%	48,181 $1.74 Million
Q3 2024 Nov 04, 2024	BUY	$25.77 - $35.16 $111,532 - $152,172	4,328 Added 10.83%	44,295 $1.38 Million
Q2 2024 Aug 08, 2024	BUY	$25.99 - $33.85 $8,186 - $10,662	315 Added 0.79%	39,967 $1.07 Million
Q1 2024 Apr 29, 2024	SELL	$27.11 - $35.17 $89,137 - $115,638	-3,288 Reduced 7.66%	39,652 $1.35 Million
Q4 2023 Feb 02, 2024	BUY	$22.72 - $29.68 $156,154 - $203,990	6,873 Added 19.06%	42,940 $1.24 Million
Q3 2023 Oct 30, 2023	BUY	$27.57 - $32.91 $534,086 - $637,532	19,372 Added 116.03%	36,067 $994,000
Q2 2023 Jul 31, 2023	BUY	$29.91 - $38.73 $120,238 - $155,694	4,020 Added 31.72%	16,695 $502,000
Q1 2023 Apr 25, 2023	BUY	$34.93 - $42.03 $2,584 - $3,110	74 Added 0.59%	12,675 $459,000
Q4 2022 Feb 01, 2023	BUY	$31.09 - $37.88 $11,347 - $13,826	365 Added 2.98%	12,601 $449,000
Q3 2022 Oct 25, 2022	BUY	$28.79 - $35.41 $15,085 - $18,554	524 Added 4.47%	12,236 $414,000
Q2 2022 Jul 25, 2022	SELL	$25.33 - $34.25 $7,624 - $10,309	-301 Reduced 2.51%	11,712 $339,000
Q1 2022 Apr 25, 2022	BUY	$28.51 - $32.9 $30,562 - $35,268	1,072 Added 9.8%	12,013 $388,000
Q4 2021 Jan 28, 2022	BUY	$26.37 - $34.22 $20,568 - $26,691	780 Added 7.68%	10,941 $319,000
Q3 2021 Oct 26, 2021	BUY	$23.54 - $31.39 $14,830 - $19,775	630 Added 6.61%	10,161 $271,000
Q2 2021 Jul 26, 2021	BUY	$26.72 - $33.19 $40,400 - $50,183	1,512 Added 18.86%	9,531 $293,000
Q1 2021 Apr 27, 2021	BUY	$24.15 - $31.45 $193,658 - $252,197	8,019 New	8,019 $210,000

Others Institutions Holding SUPN

# of Institutions

312

Shares Held

61.7M

Call Options Held

18.4K

Put Options Held

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.57B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meritage Portfolio Management, based on Form 13F filings with the SEC.

News

Stay updated on Meritage Portfolio Management with notifications on news.

Account

Meritage Portfolio Management Supernus Pharmaceuticals, Inc. Transaction History